CoChat

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

Open access
Zappasodi, Roberta, Merghoub, Taha, Wolchok, Jedd D. · 2018 · Cancer Cell
Cited by 106

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Correspondence: merghout@mskcc.org (T.M.), wolchokj@mskcc.org (J.D.W.). DECLARATION OF INTERESTS J.D.W. is a paid consultant to Advaxis, Bristol-Myers Squibb, Merck, Medimmune, Celgene, and Genentech and receives research funding from Bristol-Myers Squibb, Merck, Genentech, and Medimmune and honoraria from Ono Pharmaceuticals. J.D.W. is a cofounder and paid consultant and reports stock option ownership in Potenza Therapeutics, Tizona Therapeutics, and Imvaq. J.D.W. is a paid consultant and reports stock option ownership in Beigene and Apricity. J.D.W. is a paid consultant to Surface Oncology, Polaris, Polynoma, Array, Ascentage, Puretech, Chugai, FStar, Amgen, Sellas Life Sciences, Serametrix, Neon, Eli Lilly, Psioxus, Syndax, Recepta, Amgen, and Puretech and reports stock option ownership in Adaptive Biotech. T.M. is a co-founder of Imvaq. HHS Public Access Author manuscript Cancer Cell. Author manuscript; available in PMC 2019 October 08.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2018.09.008

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 106

Metadata

Authors
Zappasodi, R., Merghoub, T., & Wolchok, J. D.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2018-10
Volume
34
Issue
4
Pages
690
ISSN
1535-6108 (ISSN-L)
OpenAlex
W4243848630
Cited by
106
References
25
FWCI
4.04
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.